Anebulo Pharmaceuticals, Inc. ( ANEB) - Key Metrics
ANEB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.05 | -$0.03 | -$0.03 |
| 2026Q1 | $0 | -$0.05 | -$0.03 | -$0.03 |
| 2025Q4 | $0 | -$0.05 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.06 | -$0.06 | -$0.06 |
| 2025Q2 | $0 | -$0.09 | -$0.05 | -$0.05 |
ANEB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.18 |
| 2026Q1 | 0% | -11.90 |
| 2025Q4 | 0% | -6.90 |
| 2025Q3 | 0% | -7.97 |
| 2025Q2 | 0% | -4.68 |
ANEB
Price: $0.32
52 week price:
Earnings Per Share: -0.18 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1471
Market Capitalization: 13.1 million